Available in injectable and topical formulations depending on treatment goals
Previous Diagnosis of Heart Disease or Polycystic Ovary Syndrome (PCOS): Individuals with a history of heart disease or PCOS have an increased risk of insulin resistance and prediabetes
* : , Science, 27, 2024,vol 385, issue 6707, 438-446 , , 5 GLP-1
More than 2,600 patients underwent Semaglutide for up to 68 weeks, and 1,500 secured placeboes within these four studies
Semaglutide is contraindicated in people with a personal or family history of medullary thyroid carcinoma, MEN 2 syndrome, type 1 diabetes, and during pregnancy